By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Dendreon Corporation 

3005 First Avenue

Seattle  Washington  98121  U.S.A.
Phone: 206-256-4545 Fax: 206-256-0571


SEARCH JOBS


Industry
Biotechnology






Company News
Dendreon Corporation (DNDN) Provides Update On Restructuring Process 1/28/2015 11:30:20 AM
Dendreon Corporation (DNDN) Announces Strong Commercial Start To 2015 1/14/2015 7:55:05 AM
Dendreon Corporation (DNDN) Heads for Bankruptcy Auction Without $275 Million Minimum Bidder 12/31/2014 5:59:43 AM
Troubled Dendreon Corporation (DNDN) Files For Chapter 11 Bankruptcy 11/10/2014 5:56:06 AM
Struggling Dendreon Corporation (DNDN) Plunges After Warning Investors Of Debt Woes 8/13/2014 6:03:14 AM
Flailing Dendreon Corporation (DNDN) Brings In Ex-Johnson & Johnson (JNJ) Exec For Top CEO Post 7/31/2014 6:37:54 AM
Financially Troubled Dendreon Corporation (DNDN) Loses Its CEO 6/9/2014 4:30:01 PM
Dendreon Corporation (DNDN) Release: Treatment With PROVENGE® (Sipuleucel-T) Induces Antigen Spread Associated With Overall Survival Benefits In Advanced Prostate Cancer 5/20/2014 10:18:15 AM
Dendreon Corporation (DNDN) Announces Presentation Of PROVENGE┬« (sipuleucel-T) And DN24-02 Immuno-Oncology Data At The 2014 American Society of Clinical Oncology Annual Meeting 5/15/2014 8:08:39 AM
Dendreon Corporation (DNDN) Announces First Quarter 2014 Results 5/8/2014 9:21:00 AM
12345678910...
//-->